Philipp Freese
Corporate Officer/Principal chez MAINZ BIOMED N.V.
Fortune : 130 064 $ au 31/03/2024
Profil
Philipp Freese has held the following positions in his career: Co-Managing Director at PharmGenomics GmbH since 2013 and Chief Business Officer at Mainz Biomed NV since 2015.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MAINZ BIOMED N.V.
0,75% | 04/04/2023 | 126 276 ( 0,75% ) | 130 064 $ | 31/03/2024 |
Postes actifs de Philipp Freese
| Sociétés | Poste | Début |
|---|---|---|
| MAINZ BIOMED N.V. | Corporate Officer/Principal | 01/07/2023 |
PharmGenomics GmbH
 PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MAINZ BIOMED N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
PharmGenomics GmbH
PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Health Technology |
